GHK-Cu levels in the body decline significantly with age
This origin should be understood as a biochemical research background, not as evidence of clinical use, consumer suitability, or therapeutic validation
It stimulates the growth factors EGF and VEGF, activates the FAK-paxillin pathway in tendon fibroblasts, and increases growth hormone receptor expression
Parnis FX, Coleman RE, Harper PG, et al
However, different from the preclinical literature, we did not observe DA decreases in the ventral striatum, which could reflect differences in experimental procedures or interspecies differences
Sharma et al